|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 07, 2015 ) The report, Infectious Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. In addition, it discusses the major drivers that influence the growth of the market, challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.
This report covers the present scenario and the growth prospects of the infectious diseases market in US for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of drugs administered to treat infectious diseases caused by bacteria, viruses, fungi, and parasites.
The report presents vendor landscape and a corresponding detailed analysis of the top vendors in the infectious diseases market in US. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
The analysts forecast infectious diseases market in US to grow at a CAGR of 3.37% over the period 2014-2019.
Human beings are prone to various kinds of infections. Infectious diseases are caused by various pathogenic microorganisms such as bacteria, fungi, parasites, and viruses.
Antimicrobials are used to treat infections. They act by killing or resisting the growth of the microorganisms. They either act via the host defense system or directly target the causative agent. Based on the target organism, antimicrobials can be classified into anti-bacterial, anti-viral, anti-fungal, and anti-parasitic drugs.
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=389662 .
Key Vendors
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
Other Prominent Vendors
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Bristol-Myers Squibb
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Sanofi
Vertex
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=389662 .
Market Driver
Rise in patient population
Market Challenge
Generic erosion
Market Trend
Emergence of IFN-free therapies
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=389662 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
